Stephen Perry Kymanox

Stephen Perry is the CEO and Founder of Kymanox – a diversified and global professional services company solely focused on the Pharmaceutical, Biotechnology, Medical Device, and Combination Product industries. Stephen has extensive CGxP experience as a Process Engineer, Technical Project Manager, Quality Auditor, and Regulatory Strategist. Stephen leads a team of 300 professionals worldwide and has been formally recognized as a top CEO in the Research Triangle Park (RTP) region. As an entrepreneur, Mr. Perry has successfully attracted growth capital from WestView Capital Partners and has further grown the unique Kymanox platform with the acquisition of four companies.

Mr. Perry has also helped several CEOs raise Series A venture capital. Before starting Kymanox in 2004, Stephen had various leadership roles supporting scale-up, start-up, and commercialization initiatives at Abbott Laboratories (now AbbVie), FujiFilm Diosynth Biotechnologies (a global CDMO), and Human Genome Sciences (now GSK). Stephen has a diverse educational background with a high-honors bachelor’s degree in Chemical Engineering from the University of Notre Dame and studied at the graduate level at Purdue University. Stephen is a long-time supporter of the International Society of Pharmaceutical Engineering (ISPE), Parental Drug Association (PDA), Project Management Institute (PMI), and Regulatory Affairs Professional Society (RAPS).